The first premium strains launched are Medizin Silver Reserve and Medizin GMO. They are now available at Planet 13’s Medizin Dispensary at 4850 W. Sunset Road, Las Vegas.

For those who want an invigorating and energizing experience, Medizin Silver Reserve is a highly sought-after sativa-dominant hybrid strain, beloved by cannabis enthusiasts for its exceptional balance between uplifting and relaxing effects.

Medizin GMO also known as “Garlic Cookies,” is a potent indica-dominant hybrid strain created by crossing Girl Scout Cookies with Chemdawg. Known for its unique flavor profile and powerful effects, GMO is a strain that leaves a lasting impression.

“We are constantly innovating and offering our customers the best new products,” said David Farris, Planet 13 VP of Sales & Marketing. “Based on the early feedback we’ve received we know our new Medizin Live Rosin Vape Carts will be very popular and we look forward to rolling out additional premium strains.”

For more information, and to shop online or in store visit: https://www.planet13dispensaries.com/

About Planet 13
Planet 13 (http://www.planet13holdings.com) is a vertically integrated cannabis company, with award-winning cultivation, production and dispensary operations in Las Vegas and Orange County, California. Planet 13 also holds a medical marijuana treatment center license in Florida and a conditional Social-Equity Justice Involved dispensing license in the Chicago region of Illinois. Planet 13’s mission is to build a recognizable global brand known for world-class dispensary operations and create innovative cannabis products. Licensed cannabis activity is legal in these states but remains illegal under U.S. federal law. Planet 13’s shares trade on the Canadian Securities Exchange (CSE) under the symbol PLTH and are quoted on the OTCQX under the symbol PLNHF.

Cautionary Note Regarding Forward-Looking Information
This news release contains forward-looking information and forward-looking statements within the meaning of applicable securities laws. All statements, other than statements of historical fact, are forward-looking statements and are often, but not always, identified by phrases such as “plans”, “expects”, “proposed”, “may”, “could”, “would”, “intends”, “anticipates”, or “believes”, or variations of such words and phrases. In this news release, forward-looking statements relate to the launch of Medizin Solventless Live Rosin Vape Cartridges and subsequent performance. Such forward-looking statements reflect what management of the Company believes, or believed at the time, to be reasonable assumptions and accordingly readers are cautioned not to place undue reliance upon such forward-looking statements and that actual results may vary from such forward-looking statements. These assumptions, risks and uncertainties which may cause actual results to differ include, among others, the potential that regulatory approval of the proposed transaction may not be received or may be delayed or that other conditions to the closing of the proposed transaction may not be satisfied, the potential impact on the Company’s business or stock price due to the announcement of the proposed transaction, the occurrence of any event, change or other circumstances that could give rise to the termination of the Purchase Agreement and those assumptions, risks and uncertainties discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 and any of the Company’s subsequent periodic reports filed with the U.S. Securities and Exchange Commission at http://www.sec.gov and on SEDAR at http://www.sedar.com. Forward-looking statements contained herein are made only as to the date of this press release and we assume no obligation to update or revise any forward-looking statements should they change, except as required by law. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

For further inquiries, please contact:
LodeRock Advisors Inc., Planet 13 Investor Relations
[email protected]

Robert Groesbeck or Larry Scheffler
Co-Chief Executive Officers
[email protected]

Media inquiries:
Colin Trethewey / PRmediaNow Communications
[email protected]

Media Contact

Colin Trethewey, Planet 13, 813.480.1354, [email protected], https://www.planet13dispensaries.com/

SOURCE Planet 13